Skip to main content
International Journal of Molecular Sciences logoLink to International Journal of Molecular Sciences
. 2024 Nov 11;25(22):12080. doi: 10.3390/ijms252212080

Correction: Belosludtsev et al. Alisporivir Treatment Alleviates Mitochondrial Dysfunction in the Skeletal Muscles of C57BL/6NCrl Mice with High-Fat Diet/Streptozotocin-Induced Diabetes Mellitus. Int. J. Mol. Sci. 2021, 22, 9524

Konstantin N Belosludtsev 1,*, Vlada S Starinets 1,2, Eugeny Yu Talanov 2, Irina B Mikheeva 2, Mikhail V Dubinin 1, Natalia V Belosludtseva 2
PMCID: PMC11594190  PMID: 39596548

The original publication [1] was lacking a reference to a previous study [2] conducted on the same cohort of mice and published by the same authors, from which panels (a), (c), and (d) of Figure 1 (the validation of a mouse model of diabetes using the intraperitoneal glucose tolerance test) was reused without citation. The correct legend for Figure 1 is shown below.

Figure 1.

Figure 1

Induction scheme of diabetes mellitus (a), body weight gain (b), intraperitoneal glucose tolerance test, IPGTT (c), and intraperitoneal insulin sensitivity test, IPIST (e) in control (CTR), alisporivir-treated control (CTR+Ali), diabetic (DM), and alisporivir-treated diabetic (DM+Ali) mice. The total areas under the curve (AUC) of the IPGTT (d) and IPIST (f) are shown. The tests were conducted on the 60th day from the beginning of the experiment. ** In subfigure b, the difference between the CTR and DM+Ali groups is significant at p < 0.01. **** differences between the CTR and DM groups are significant at p < 0.0001. All data are presented as mean ± SEM (n = 5). Data in subfigures (a,c,d) are from Belosludtseva et al. Biology 2021, 10, 839, doi: 10.3390/biology10090839.

The authors state that the scientific conclusions are unaffected. This correction was approved by the Academic Editor. The original publication has also been updated.

Footnotes

Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

References

  • 1.Belosludtsev K.N., Starinets V.S., Talanov E.Y., Mikheeva I.B., Dubinin M.V., Belosludtseva N.V. Alisporivir Treatment Alleviates Mitochondrial Dysfunction in the Skeletal Muscles of C57BL/6NCrl Mice with High-Fat Diet/Streptozotocin-Induced Diabetes Mellitus. Int. J. Mol. Sci. 2021;22:9524. doi: 10.3390/ijms22179524. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Belosludtseva N.V., Starinets V.S., Mikheeva I.B., Serov D.A., Astashev M.E., Belosludtsev M.N., Dubinin M.V., Belosludtsev K.N. Effect of the MPT Pore Inhibitor Alisporivir on the Development of Mitochondrial Dysfunction in the Heart Tissue of Diabetic Mice. Biology. 2021;10:839. doi: 10.3390/biology10090839. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from International Journal of Molecular Sciences are provided here courtesy of Multidisciplinary Digital Publishing Institute (MDPI)

RESOURCES